|
|
Yes |
|
|
(n = 39) |
No |
|
|
|
(n = 168) |
|
|
|
|
Treatment setting |
In patient |
31 (79.5%) |
89 (53.0%) |
*0.003 |
|
Outpatient |
8 (20.5%) |
79 (47.0%) |
|
Gender |
Male |
18 (46.2%) |
98 (58.3%) |
0.167 |
|
Female |
21 (53.8%) |
70 (41.7%) |
|
Diagnosis |
Leukemia/ lymphoma |
17 (43.6%) |
93 (55.4%) |
0.185 |
|
Solid |
13 (33.3%) |
51 (30.4%) |
0.717 |
|
CNS |
9 (23.1%) |
24 (14.3%) |
0.177 |
Acute Nausea Degree categorize |
No Nausea |
13 (35.1%) |
120
(72.7%) |
*<0.001 |
|
Mild nausea |
5 (13.5%) |
13 (7.9%) |
0.313 |
|
Moderate nausea |
9 (24.3%) |
22 (13.3%) |
0.116 |
|
Severe nausea |
10 (27.0%) |
10 (6.1%) |
*<0.001 |
Acute Vomiting Frequency |
1-2 times |
12 (32.4%) |
20
(12.1%) |
*0.028 |
|
3 times or more |
7 (18.9%) |
3 (1.8%) |
*<0.001 |
|
None |
18 (48.6%) |
142 (86.1%) |
*<0.001 |
Acute Food Tolerance |
Yes |
14 (37.8%) |
97 (58.8%) |
*0.014 |
|
No |
23 (62.2%) |
68 (41.2%) |
|
Acute Food Tolerance Degree (%) Categorize |
Severe |
16
(43.2%) |
34 (20.6%) |
*0.006 |
|
Moderate |
5 (13.5%) |
17 (10.3%) |
0.622 |
|
Mild |
4 (10.8%) |
34 (20.6%) |
0.147 |
|
Normal |
12 (32.4%) |
80 (48.5%) |
0.056 |
Delayed Nausea Degree Categorize (%) |
No Nausea |
3 (7.7%) |
134 (79.8%) |
*<0.001 |
|
Mild nausea |
12 (30.8%) |
15 (8.9%) |
*<0.001 |
|
Moderate nausea |
11 (28.2%) |
15 (8.9%) |
*0.001 |
|
Severe nausea |
13 (33.3%) |
4 (2.4%) |
*0.001 |
Delayed Vomiting Frequency |
1-2 times |
28 (71.8%) |
0
(0.0%) |
*<0.001 |
|
3 times or more |
11 (28.2%) |
0 (0.0%) |
*<0.001 |
|
None |
0 (0.0%) |
168 (100.0%) |
*<0.001 |
Delayed Food Tolerance |
Yes |
8 (20.5%) |
113 (67.3%) |
*<0.001 |
|
No |
31 (79.5%) |
55 (32.7%) |
|
Delayed Food Tolerance Degree (%) Categorize |
Severe |
19
(48.7%) |
18 (10.7%) |
*<0.001 |
|
Moderate |
7 (17.9%) |
17 (10.1%) |
0.169 |
|
Mild |
8 (20.5%) |
36 (21.4%) |
0.900 |
|
Normal |
5 (12.8%) |
97 (57.7%) |
*<0.001 |